The answers below summarize what researchers and regulators know so far based on current clinical trials and public data
Its unusual for the FDA to go against the recommendations of the Pharmacy Compounding Advisory Committee (PCAC), but it has happened at least once before
The dose range is 1.6-4.8 mg per injection: The standard KLOW dose is 3.2 mg total per injection: 2 mg GHK-Cu plus 0.4 mg each of BPC-157, TB-4, and KPV The low-end of the dose range is 1.6 mg, anchored on 1 mg of GHK-Cu with 200 mcg each of BPC-157, TB-4, and KPV The high-end of the dose range is 4.8 mg, anchored on 3 mg of GHK-Cu with 600 mcg each of BPC-157, TB-4, and KPV There is no trial-established dose for KLOW the dose range is mechanistically derived from a combination of each peptide
V draw = 2 mg 2.5 mL50 mg = 0.1 mL = 10 units Injury (2 mL water with BPC-157 anchor) Payload: GHK-Cu 2.5 mg BPC-157 0.5 mg TB-4 0.5 mg
GHK-Cu, also called copper peptide, is often used in ReSpa Palm Beachs GLOW Peptide Therapy to support healthier-looking skin and hair
Most side effects, like nausea or headache, last a few days and improve once the medication is finished